(MJCTT) Author’s Guide

1. Scope of the Journal

At the Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT), we are committed to publishing high-impact, peer-reviewed research that transforms therapeutic science and clinical outcomes.

We welcome original submissions in the following key areas:

• Clinical Trials – Including interventional and observational studies that enhance evidence-based treatment.
• Drug Development & Pharmaceutical Research – Spanning early discovery to late-stage clinical evaluation.
• Biologics, Devices & Treatment Efficacy – Focused on innovative therapies and clinical applications.
• Translational Medicine & Personalized Therapies – Bridging the lab and bedside to optimize care.
• Clinical Pharmacology & Toxicology – Exploring drug interactions, safety, and efficacy.
• Regulatory Science & Research Ethics – Covering consent, compliance, and human subject protection.
• Case Reports & Trial Protocols – Featuring unique clinical insights and trial design transparency.

As an open-access journal, MJCTT ensures that your research is freely accessible to clinicians, scientists, and policymakers worldwide—driving innovation and impact without barriers.

2. Types of Manuscripts Accepted

At the Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT), we actively seek high-quality, peer-reviewed submissions that advance clinical and therapeutic research. Authors are encouraged to submit the following types of manuscripts:

• Original Research Articles – Comprehensive reports of clinical trials, interventional studies, or therapeutic investigations that generate new evidence.
• Review Articles – Thorough evaluations and critical summaries of clinical methods, treatment innovations, and therapeutic trends.
• Clinical Case Reports – Insightful documentation of rare, challenging, or educational patient cases with translational relevance.
• Brief Reports – Concise yet impactful findings from pilot studies, feasibility analyses, or early-phase clinical research.
• Editorials – Authoritative perspectives, expert commentaries, or invited reflections on critical issues in clinical trials and therapies.
• Letters to the Editor – Constructive opinions, scholarly discussions, or responses related to previously published articles or emerging clinical topics.

Each manuscript is carefully evaluated through a rigorous peer-review process, and once accepted, published with global open-access visibility—ensuring your research reaches clinicians, scientists, and decision-makers without paywalls.

To ensure smooth peer review and fast-track publication, authors submitting to the Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT) are advised to carefully follow the manuscript preparation guidelines outlined below:

📄 A. Formatting Requirements

To maintain consistency and clarity across all submissions, please adhere to the following formatting standards:

• Submit manuscripts in Microsoft Word (.doc or .docx) format
• Use Times New Roman, 12-point font
• Set line spacing to 1.5 throughout
• Number pages consecutively
• Include a title page that features:
  • Full manuscript title
  • All author names and institutional affiliations
  • Contact information for the corresponding author

🧠 B. Abstract and Keywords

An abstract and keywords are mandatory for original research and review articles. Please follow these specifications:

• Maximum abstract length: 250 words
• For original research articles, use a structured abstract with these headings:
  • Background
  • Methods
  • Results
  • Conclusion
• After the abstract, list 4 to 6 relevant keywords to enhance discoverability

📚 C. Main Text Structure

For original research submissions, please organize the main text as follows:

1. Introduction
2. Methods
3. Results
4. Discussion
5. Conclusion

Other article types (e.g., reviews, case reports, editorials) may use a flexible format that suits their content and narrative structure. However, clarity, logic, and flow should always be prioritized.

📬 Need Help?
For questions regarding formatting, submission, or article types, contact the editorial office at: editors_mjctt@mogitojournals.org

4. References and Citation Style

Accurate referencing is essential to uphold scientific integrity and ensure traceability of clinical evidence. Authors submitting to MJCTT must follow these citation and reference standards:

🔹 Use Vancouver Style

All manuscripts must follow the Vancouver citation format, a numbered referencing style commonly used in clinical and biomedical journals.

🔹 Cite in Sequential Order

References should be numbered consecutively in the order they appear in the text. Each reference number must match its corresponding citation exactly.

🔹 Include Only Accessible, Published Sources

Citations must refer to publicly accessible, peer-reviewed, or published sources. Avoid citing unpublished data, personal communications, or inaccessible documents.

🔹 Ensure Accuracy and Completeness

All reference entries should be complete and properly formatted, including:

• Author(s)
• Title of article
• Journal name (abbreviated)
• Year of publication
• Volume and issue
• Page range
• DOI (if available)

Incorrect or incomplete references may result in delayed peer review or rejection.

📌 Reminder: Use a citation manager (e.g., Zotero, EndNote, Mendeley) to maintain consistency and prevent formatting errors.

5. Figures and Tables

To ensure clarity and professionalism in clinical research presentation, authors submitting to MJCTT must adhere to the following formatting guidelines for figures and tables:

🔹 Placement

• Place all figures and tables either at the end of the manuscript or upload them as separate, clearly labeled files during submission.

🔹 Numbering

• Assign and cite each figure or table in consecutive order (e.g., Figure 1, Table 1) as they appear in the text.

🔹 Legends

• Provide a concise, descriptive legend for each figure and table that explains its content without referencing the main text.

🔹 Image Quality

• All figures must be submitted in high-resolution format, with a minimum of 300 DPI to ensure print and digital clarity.

📌 Tip: Use accepted file formats (JPEG, PNG, TIFF, or EPS) and avoid low-resolution screenshots.

6. Ethical Considerations

At the Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT), we uphold the highest standards of research ethics and publication integrity. All authors must comply with the following ethical requirements when submitting to MJCTT:

🔹 A. Human and Animal Research Ethics

• All studies involving human participants or animal subjects must include formal documentation of ethics committee or IRB approval.
• Authors must confirm that informed consent was obtained from human participants in accordance with the Declaration of Helsinki.
• Research must fully comply with national and institutional ethical guidelines governing the use of human and animal subjects.

🔹 B. Originality and Plagiarism Policy

• Submitted manuscripts must be original, unpublished, and not under review elsewhere.
• MJCTT conducts plagiarism screening using trusted detection software (e.g., iThenticate).
• Authors are fully accountable for the authenticity, accuracy, and originality of their work.
• Any instances of plagiarism or data manipulation will result in rejection and potential institutional notification.

🔹 C. Authorship and Contribution Transparency

• MJCTT adheres to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines.
• All listed authors must have made a substantial contribution to the design, execution, or interpretation of the research.
• Authorship changes post-submission require written agreement from all authors and must be approved by the editorial board.

📢 Note to Authors: Ethical compliance is not optional—it is foundational. Any breach of these standards may result in retraction, blacklisting, and notification to affiliated institutions or funders.

7. Peer Review Process

At the Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT), we are committed to a transparent, fair, and timely peer review process that upholds the scientific integrity of every publication.

🔹 Rigorous Double-Blind Review

All submitted manuscripts undergo a double-blind peer review to eliminate bias. Author and reviewer identities are kept confidential throughout the process.

🔹 Expert Evaluation

Each submission is reviewed by at least two independent experts with relevant subject-matter expertise. Reviewers assess scientific rigor, clinical relevance, methodological soundness, and ethical compliance.

🔹 Efficient Turnaround

• Average review timeline: 4 to 6 weeks
• Authors receive a formal editorial decision accompanied by constructive reviewer comments
• Manuscripts may require minor or major revisions before final acceptance

🔹 Editorial Oversight

All decisions are made by the editorial board in consultation with reviewers. The final acceptance of any manuscript depends on satisfactory revision and adherence to ethical and formatting standards.

📢 Note: Our peer review model fosters academic dialogue, improves manuscript quality, and accelerates the responsible dissemination of therapeutic research.

8. Open Access Policy

Immediate Free Access with Creative Commons License

MJCTT is a fully open access journal. All published articles are freely available immediately upon publication under the Creative Commons Attribution License (CC BY 4.0), enabling unrestricted use, distribution, and reproduction with proper credit.

9. Article Processing Charges (APC)

Affordable Fees with Waivers & Launch Discounts

To support open access and journal operations, MJCTT applies a modest Article Processing Charge (APC). Fee waivers or discounts are available for authors from low-income countries or upon justified request.

To Celebrate MJCTT’s launch — the first 10 accepted manuscripts will be published free of charge. Submit now and enjoy open access publishing at no cost.

For the latest APC details, contact our editorial office: editors_mjctt@mogitojournals.org

10. Submission Instructions

How to Submit Your Manuscript to MJCTT: Simple Email Submission Process

Authors are invited to submit manuscripts via email to: mjctt@mogitojournals.org

Please include the following documents with your submission:

• Cover Letter
• Manuscript File (including title page and abstract)
• Figures and Tables (if applicable)
• Ethics Approval Documentation (if applicable)

Ensure all files are clearly labeled and submitted in editable formats (e.g., .docx, .jpg, .png, or .pdf for figures).

11. Contact Information

For further inquiries, please contact:
editors_mjctt@mogitojournals.org
www.mogitojournals.org